12-10-2008

Dergi Hakkında
Yayın Kurulu
Danışma Kurulu
Yazım Kuralları
Yayın Hakları Devir Formu
Online Makale İşlemleri
İletişim
Oftalmoloji Dergisi
ISSN: 1300-0365
Dil: Türkçe

 

REVIEW ARTICLES


The Role Of Vascular Endothelial Growth Factor In Ocular Angiogenesis

Dr. Burak TURGUT,a Dr. Mete GÜLER, a Dr. Tamer DEMİR, a Dr. Peykan TÜRKÇÜOĞLU, a Dr. Ülkü ÇELİKERa
aGöz Hastalıkları AD, Fırat Üniversitesi Tıp Fakültesi, ELAZIĞ



Angiogenesis is defined as the formation of new capillaries from a pre-existing vasculature. This process is very important in physiologic conditions. It is only induced during the female reproductive cycle, tissue repair and wound healing. In the eye diseases associated with angiogenesis, this delicate balance is disturbed. Angiogenesis is a potentially visually threatening complication of eye diseases such as diabetic retinopathy (DR) and age-related macular degeneration (AMD), retinopathy of prematurity (ROP), and a large number of other eye conditions. Because of its importance in wound healing, tumour growth, and other pathological situations, angiogenesis has been extensively studied in the fields of oncology, rheumatology, cardiology, and ophthalmology. Vascular endothelial growth factor (VEGF) is a highly specific mitogen for vascular endothelial cells and it induces endothelial cell proliferation, promotes cell migration, and inhibits apoptosis. VEGF that induces angiogenesis as well as permeabilization of blood vessels in vivo, plays a central role in the regulation of angiogenesis. An antiangiogenic therapy is aimed at inhibiting the growth of new blood vessels and should prevent onset or progression of neovascularization. Several antineovascular agents antagonize the function of VEGF, by blocking its proangiogenic activity. The understanding of VEGF’s effects on angiogenesis and vascular permeability and VEGF modulation will give us new insights about the treatment of eye diseases associated angiogenesis. New studies are needed for preventing or treating conditions that will lead to significant visual loss or blindness, driven by unregulated angiogenesis.

Keywords: Vascular endothelial growth factors; neovascularization, pathologic; neovascularization, physiologic

Turkiye Klinikleri J Ophthalmol 2007, 16:38-46

E-mail To Friend This Page Printer Friendly Page
 
 
 ARAMA
  
 Ayrıntılı Arama
 GİRİŞ
 Kullanıcı Adı :
 
 Şifre  
   Beni Hatırla
 Şifremi Unuttum
 Kayıt Ol
 
 
 
 
 
 
 
 

Yasal uyarı: Bu sitede yayınlanan resim, yazı ve diğer uygulamaların her hakkı Ortadoğu Reklam Ve Yayıncılık A.Ş. 'ye aittir. Kaynak gösterilmeden kullanılamaz. Bu site hekimleri sağlık alanında bilgilendirmeye yönelik hazırlanmıştır. Sitede yer alan bilgiler tanı ve tedavi amaçlı kullanıldığında sorumluluk tamamen kullanıcıya aittir. Siteye girmekle bu şartları okumuş, anlamış ve kabul etmiş sayılırsınız.